期刊文献+

反应性氮代谢产物对NK细胞抗K562细胞活性的影响 被引量:2

Effects of reactive nitrogen metabolites on NK cell-mediated killing of K562 cells
原文传递
导出
摘要 目的探讨外源性、内源性反应性氮代谢产物(RNM)及其清除剂硫普罗宁(TIP)、还原型谷胱甘肽(GSH)、二氢氯组胺(DHT)对NK细胞抗K562细胞活性的影响。方法体外合成外源性ONOO^-,在NK+K562细胞培养体系中,观察外源性ONOO^-及其清除剂对K562细胞抑制率(KIR)、肿瘤坏死因子α(TNF—β)和干扰素γ(IFN-γ)的含量及NK细胞活性影响。以白细胞介素2(IL-2)+植物血凝素(PHA)激活单核细胞(MO)呼吸爆发产生内源性RNM,在MO+NK+K562细胞培养体系中,观察内源性RNM对NK细胞活性的影响,然后加入RNM清除剂观察RNM和NK细胞活性的变化。结果在NK和K562细胞培养体系中加入外源性ONOO^-后,NK活细胞率从(93.17±2.57)%下降到(71.87±1.02)%(P〈0.01),KIR从(67.47±2.64)%下降到(43.44±2.87)%(P〈0.01);加入TIP、GSH和DHT后,NK活细胞率分别升高至(91.13±3.67)%(P〈0.05)、(88.03±1.46)%(P〈0.05)和(73.60±2.76)%(P〉0.05),KIR上升至(61.58±1.89)%(P〈0.05)、(60.68±2.07)%(P〈0.05)和(45.26±3.31)%(P〉0.05)。以IL-2+PHA+NK+K562为对照,在NK+K562+MO混合培养体系中加入IL-2+PHA,RNM含量从(82.10±6.60)μmom/L增至(193.65±5+95)μmom/L(P〈0.01),KIR从(90.64±3.06)%下降至(61.29±2.22)%(P〈0.01);加入TIP、GSH和DHT后,RNM含量分别降低至(91.32±6.81)μmom/L(P〈0.05)、(84.66±5.99)μmom/L(P〈0.05)和(188.92±5.00)μmom/L(P〉0.05),KIR上升至(84.31±4.56)%(P〈0.05)、(81.65±3.09)%(P〈0.05)和(72.20±4.10)%(P〈0.05)。结论外源性ONOO^-和MO呼吸爆发产生的RNM均可使NK细胞的抗K562细胞活性下降。TIP和GSH可通过清除RNM保护NK细胞,提高NK细胞抗K562细胞活性。 Objective To explore the effects of the exogenous and endogenous reactive nitrogen metabolites (RNM) as NK cell inhibitors on NK cell-mediated killing of K562 cells and the influence of Tiopronin (TIP), glotamylcysteinylglycine (GSH) and histamine dihydroehloride (DHT) as RNM scavengers on reversing the suppressing effect of RNM. Methods The exogenous ONOO^- was administered in the NK + K562 culture system, then the RNM scavengers were added in the NK + K562 + ONOO^- culture system, respectively. The concentrations of RNM, TNF-β and IFN-γ, K562 cell inhibition rate (KIR) and the percentage of living NK cells were examined. IL-2 + PHA were used as monocyte (MO) activators in the culture system of MO + NK + K562. Then TIP, GSH and DHT were administered and the parameters of NK cell activity were analyzed. Results After exogenous ONOO^- was administered in NK + K562 culture system, the percentage of living NK cells was decreased from (93. 17 ± 2.57 ) % to (71.87 ± 1.02) % (P 〈 0.01 ) and KIR was decreased from (67.47 ± 2.64) % to (43.44 ± 2.87) % (P 〈 0.01 ). When TIP, GSH and DHT were administered into the systems, the percentage of living NK cells was increased to (91.13±3.67)% (P〈0.05), (88.03±1.46)% (P〈0.05), (73.60±2.76)% (P〉0.05), respectively ; KIR was increased to (61.58 ± 1.89 ) % ( P 〈 0.05 ), ( 60.68 ± 2.07 ) % ( P 〈 0.05 ) and (45.26± 3.31 ) % ( P 〉 0.05 ), respectively. When IL-2/PHA were administered in the NK + K562 + MO culture system, RNM products was increased from (82.10 ±6.60)μmom/L to (193.65 ±5.95) μmom/L (P 〈 0.01 ) ;KIR was decreased from (90.64 ± 3.06 ) % to ( 61.29 ± 2.22 ) % ( P 〈 0.01 ). When the TIP, GSH and DHT were administered in the systems, RNM products were decreased to (91.32±6.81 ) μmom/L (P 〈 0. 05), (84. 66 _ 5.99 )μmom/L ( P 〈 0.05 ) and ( 188.92 ± 5.00 ) μmom/L ( P 〉 0.05 ), respectively; KIR was increased to ( 84. 31 ± 4. 56) % ( P 〈 0.05 ), ( 81.65 ± 3.09) % ( P 〈 0.05 ) and ( 72.20 ± 4.10 ) % ( P 〈 0. 05 ), respectively. Conclusion NK Cell-mediated killing of K562 ceils can be suppressed by exogenous and endogenous RNM administration. Both of TIP and GSH can protect NK cells by scavenging RNM and enhance the antineoplasmic activity of NK cells.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2010年第4期267-271,共5页 Chinese Journal of Oncology
基金 福建省科技厅资助省属高校项目(2007F5043)
关键词 反应性氮代谢产物 杀伤细胞 天然 K562细胞 硫普罗宁 谷胱甘肽 Reactive nitrogen metabolites Killer cell, natural K562 cells Tiopronin Glutathione
  • 相关文献

参考文献13

二级参考文献66

  • 1郭健欣,潘敬新,朱元贵,骆永河,郭熙哲,蔡俊峰,李永加,李秋兰.反应性氧代谢物清除剂逆转ROM对NK细胞抗K562细胞系体外抑制作用[J].中国实验血液学杂志,2005,13(4):589-595. 被引量:4
  • 2潘敬新,林玲,郭健欣,朱元贵,蔡俊峰,郭熙哲,陈志哲.还原型谷胱甘肽抗白血病免疫佐剂作用实验研究[J].中国实验血液学杂志,2006,14(2):359-362. 被引量:5
  • 3Galea-Lauri J. Immunological weapons against acute myeloid leukaemia. Immunology,2002,107:20-27.
  • 4Buggins AG, Lea N, Gaken B, et al. Effect of costimulation and the microenvironment on antigen presentation by leukemia cell. Blood, 1999,94:3479-3490.
  • 5Buzyn A, Petit F, Ostankovitch M, et al. Membrance-bound Fas (Apo-1/CD95) ligand on leukemia cells: A mechanism of tumor immune escape in leukemia patients. Blood, 1999,94:3135-3140.
  • 6Kufner S, Zitzelsberger H, Krocell T, et al. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions. Scand J Immunol, 2005,62:86-98.
  • 7Briard D, Azzarone B, Brouty-Boye D. Importance of stromal determinants in the generation of dendritic and natural killer cells in the human spleen. Clin Exp Immunol, 2005,140:265-273.
  • 8Gao L,Fan HH, Lu HZ, et al. Impact of transfection with total RNA of K562 cells upon antigen presenting, maturation, and function of human dendritic cells from peripheral blood mononuclear cells. Transfusion, 2007,47:256-265.
  • 9Lee WC, Wang HC, Hung CF, et al. Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial. J Immunother, 2005,28:496-504.
  • 10Hsu AK, Kerr BM, Jones KL, et al. RNA loading of leukemic antigens into cord blood-derived dendritic cells for immunotherapy. Biol Blood Marrow Transplant, 2006,12:855-867.

共引文献36

同被引文献28

  • 1姚仁南,朱培元,张春雷,王涛.一氧化氮增强环磷酰胺对白血病细胞损伤效应的实验研究[J].医学研究生学报,2006,19(4):315-318. 被引量:2
  • 2VlCETTI MIGUEL R D, CHERPES T L, WATSON L J, et al. CTL induction of tumoricidal nitric oxide production by intratumoral macrophages is critical for tumor elimination[J].J Immunol, 2010, 185(11 ):6706-6718.
  • 3LI L M, KILBOURN R G, ADAMS J, etal. Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells[J]. Cancer Res, 1991, 51(10):2531-2535.
  • 4LALA P K, CHAKRABORTY C. Role of nitric oxide in carcinogenesis and tumour progression[J]. Lancet Oncol, 2001,2(3):149-156.
  • 5GARDNER P R, GARDNER A M, BRASHEAR W T, et al. Hemoglobins dioxygenate nitric oxide with high fidelity[J].J Inorg Biochern, 2006, 100(4):542-550.
  • 6LIM S, HUNG A C, PORTER A G. Focused PCR screen reveals p53 dependence of nitric oxide-induced apoptosis and up-regulation of maspin and plasminogen activator inhibitor-I in tumor cells[J]. Mol Cancer Res, 2009, 7(1):55-66.
  • 7JURASZ P, SAWlCKI G, DUSZYK M, et al. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide[J]. Cancer Res, 2001,61(1):376-382.
  • 8WEYERBROCK A, BAUMER B, PAPAZOGLOU A. Growth inhibition and chemosensitization of exogenous nitric oxide released from NONOates in glioma cells in vitro[J]. J Neurosurg, 2009, 110(1 ):128-136.
  • 9YANG Y C, XlAO D W, LIU H, et al. Mechanism of simvastatin-induced K562 cell apoptosis[J]. Pharmacology, 2009, 84(4):191-195.
  • 10RAKSHIT S, BAGCHI J, MANDAL L, et al. N-acetyl cysteine enhances imatinib-induced apoptosis of 8cr-Abl+ cells by endothelial nitric oxide synthase- mediated production of nitric oxide[J]. Apoptosis, 2009, 14(3):298-308.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部